Pioneering Efforts Produce Regenerative Products
May 29, 2015
Tissue Regenix Wound Care Inc.
Diabetic patients suffering diabetic foot ulcers (wounds) are benefiting from pioneering efforts in wound therapy. Tissue Regenix, an international medical technology company is leading the development of a range of regenerative products to make specialized replacement tissue using biological (human & animal) materials.
The company offers an expanding roster of products based on their patented dCELL® decellularization technology to provide acellular tissue scaffolds which are not rejected by the patient’s body. DermaPure® is a new decellularized human dermis product from Tissue Regenix used by physicians to help promote wound healing. Initial clinical use has demonstrated that DermaPure® allografts may have scaffold characteristics – including elasticity, porosity and bio-compatibility – comparable to natural tissue, which have been shown to promote beneficial cellular activity during healing.
The best part of Thanksgiving is spending time with your family and being grateful for your many blessings. Today, The Balancing Act is giving you three turkey leftover recipes that can infuse your holiday extras with a tasty twist.
Get swept away under the desert sky as Amber Milt takes you behind the scenes of The Band's Visit.
About 37 million people face hunger in the U.S. today — including more than 11 million children and nearly 5.4 million seniors. Hunger knows no boundaries — it touches every community in the U.S., including your own.